A Comparison of Stone Free Rate between Diuretics and Control Group in Patients Undergoing Extracorporeal Shock Wave Lithotripsy : A Prospective, Randomised, Double-Blind, Placebo-Controlled Trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210601002

Enrollment

194

Registered

2021-06-01

Start date

2020-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis patients treated with Extracorporeal Shock Wave Lithotripsy (ESWL). Extracorporeal Shock Wave Lithotripsy (ESWL) diuretics

Interventions

Furosemide 40 milligram intravenous injection 30 minute before Extracorporeal Shock Wave Lithotripsy ,Normal saline solution 4 millilitr intravenous injection 30 minute before Extracorporeal Shock Wav

Placebo Comparator Drug,Placebo Comparator Other

Furosemide,Normal Saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Urolithiasis patients treat with Extracorporeal Shock Wave Lithotripsy (ESWL)

Exclusion criteria

Exclusion criteria: 1.Pregnancy 2.Serious Urinarytract infection 3.Coagulopathy 4.Severe Hypertension

Design outcomes

Primary

Measure	Time frame
stone free rate 3 months size of stone (millimetre)on Film X-ray plain Kidney Ureter Bladder	—

Secondary

Measure	Time frame
treatment success rate 3 months size of residual stone (millimetre) on Film X-ray Kidney Ureter Bladder	—

Countries

Thailand

Contacts

Public ContactPeerapat Cheewaisrakul

Chaophraya Yommarat Hospital,Suphanburi

pom_uro@yahoo.com0892032952

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026